Acupuncture as an Adjunctive Treatment for Pain in Hospitalized Children With Sickle Cell Disease

Reece-Stremtan, Sarah; Mahmood, Laila; Margulies, Stefanie; Martin, Benjamin D.; Rohatgi, Radha; Idiokitas, Risi; Cohen, Ira Todd; Zhang, Anqing; Thaniel, Lisa; Hardy, Steven; Darbari, Deepika S.

doi:10.1016/j.jpainsymman.2021.06.003

Cited by 11 publications

(24 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…All acupuncture treatments were performed with sterile and disposable needles (averaging 14.5 needles per treatment), and needle retention ranged from 20–30 min per treatment [ 5 ]. Examples of acupuncture points selected in all studies are detailed in Table S1, in Supplemental Materials [ 5 , 6 , 8 , 9 ]. No adverse events attributable to acupuncture treatments were reported during this single patient retrospective case review [ 5 ].…”

Section: Resultsmentioning

confidence: 99%

“…Pain management during an acute vaso-occlusive episode in a pediatric patient with sickle cell disease (SCD) is challenging to treat and standard-of-care options are limited to opioids, IV fluids, adjunct ketamine infusions, regional anesthesia, and nonsteroidal anti-inflammatory drugs (NSAIDs) [ 1 , 2 , 3 , 4 ]. Acupuncture has long been studied for pain relief, however, a unified theory of its action in Western Medicine has not been accepted [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. Moreover, acupuncture for the use of pain management in pediatric patients with SCD during an acute pain episode is a vastly understudied area of medicine [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

“…Acupuncture has long been studied for pain relief, however, a unified theory of its action in Western Medicine has not been accepted [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ]. Moreover, acupuncture for the use of pain management in pediatric patients with SCD during an acute pain episode is a vastly understudied area of medicine [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

“…The purpose of this review article is to examine the existing literature regarding the use of acupuncture as an adjunctive pain treatment option in pediatric patients with SCD pain episodes. Much research potential remains for adjunct integrative pain treatment options in the pediatric population with SCD for both acute and chronic pain [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 12 , 13 ].…”

Section: Introductionmentioning

confidence: 99%

“…Current studies on the clinical efficacy or effectiveness of acupuncture for SCD-related pain in children consist of retrospective chart reviews or feasibility studies on the acceptance of acupuncture. They lack the methodological rigor needed to assess acupuncture’s benefits [ 5 , 6 , 7 , 8 , 9 , 10 , 11 , 22 , 32 ]. In 2020, the American Society of Hematology (ASH) set out guidelines for the management of both acute and chronic pain in the adult and pediatric patient population, concluding a lack of evidence on the recommendation for or against the use of acupuncture for the treatment of acute and/or chronic pain in the pediatric patients with SCD [ 4 ].…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease

Plonski

2022

Children

View full text Add to dashboard Cite

Pain management in an acute vaso-occlusive episode for pediatric patients with sickle cell disease (SCD) is challenging and often is focused on opioids, IV fluids, regional anesthesia, ketamine infusions, and non-steroidal anti-inflammatory drugs (NSAIDs). Acupuncture has long been studied as an effective method of pain relief, although the use of acupuncture in pediatric patients with SCD during an acute vaso-occlusive pain episode is vastly understudied. This article provides a review of current research regarding the use of acupuncture as a pain treatment strategy for pediatric patients with SCD experiencing acute pain. A literature review of scientific papers published within the last ten years was conducted on the topic. Five primary literature articles on acupuncture for pain management in pediatric patients with SCD were reviewed. Acupuncture is feasible and acceptable, with statistically significant findings for effectiveness as an adjunct treatment for pain in this setting. It is concluded that acupuncture is a promising and understudied therapy for the treatment of pain during an acute pain episode in pediatric patients with SCD. Hopefully, this paper stimulates interest in this specific area of medicine and prompts future research studies to be conducted to reveal conclusive outcomes.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease

Plonski

2022

Children

View full text Add to dashboard Cite

show abstract

Massage therapy for children, adolescents, and young adults: Clinical delivery and effectiveness in hematology and oncology

Rodgers-Melnick

Bartolovich

Desai

et al. 2023

Pediatric Blood & Cancer

View full text Add to dashboard Cite

Background Children, adolescents, and young adults with hematologic and/or oncologic conditions experience multiple, significant symptoms (e.g., pain, stress, and anxiety), which may be addressed by nonpharmacologic approaches such as massage therapy (MT). The purpose of this study was to describe the clinical delivery of MT provided by a certified pediatric massage therapist and assess effectiveness in two patient groups: those with sickle cell disease (SCD) or hematologic and/or oncologic conditions excluding SCD (HemOnc). Methods Investigators conducted a retrospective review of MT sessions provided to patients 0–39 years with hematologic and/or oncologic conditions at a large pediatric academic medical center. Results Between October 2019 and December 2021, 3015 MT sessions were provided to 243 patients (171 HemOnc; 72 SCD) and documented in the electronic health record. Patients (mean age: 12.21 ± 7.19 years) were generally White (49.4%) or Black/African American (43.2%), non‐Hispanic (94.2%), and 52.3% female. Patients in the SCD group (vs. patients in the HemOnc group) reported significantly higher (p < .05) pretreatment pain (6.95 vs. 4.46), stress (6.47 vs. 4.58), and anxiety (6.67 vs. 4.59). All patients reported clinically and statistically significant (p < .001) mean reductions in pain (−2.25 ± 1.87), stress (−2.50 ± 1.73), and anxiety (−2.52 ± 1.69), with patients in the HemOnc group reporting greater mean pain change (−2.54 vs. −1.87) than patients in the SCD group. Conclusions This study supports the clinical effectiveness of MT for addressing acute pain, stress, and anxiety among youth with hematologic and/or oncologic conditions. Future research is needed to identify optimal MT utilization.

show abstract

Pain screening in youth with sickle cell disease: A quality improvement study

Vroom,

Rodgers‐Melnick,

Brown

et al. 2024

Pediatric Blood & Cancer

View full text Add to dashboard Cite

BackgroundYouth with sickle cell disease (SCD) face several challenges as they age, including increased pain frequency, duration, and interference. The purpose of this study was to (i) determine the feasibility of routine pain screening; (ii) identify and describe various clinical pain presentations; and (iii) understand preferences/resources related to engaging in integrative health and medicine (IHM) modalities within an outpatient pediatric SCD clinic.MethodsDuring routine outpatient visits, patients aged 8–18 completed measures of pain frequency, duration, and chronic pain risk (Pediatric Pain Screening Tool [PPST]). Participants screening positive for (i) persistent or chronic pain or (ii) medium or high risk for persistent symptoms and disability on the PPST were asked to complete measures of pain interference, pain catastrophizing, and interest in/resources for engaging in IHM modalities.ResultsBetween March 2022 and May 2023, 104/141 (73.8%) patients who attended at least one outpatient visit were screened. Of these 104 (mean age 12.46, 53.8% female, 63.5% HbSS), 34 (32.7%) reported persistent or chronic pain, and 48 (46.2%) reported medium or high risk for persistent symptoms and disability. Patients completing subsequent pain screening measures reported a mean pain interference T‐score of 53.2 ± 8.8 and a mean pain catastrophizing total score of 24.3 ± 10.2. Patients expressed highest interest in music (55.6%) and art therapy (51.9%) and preferred in‐person (81.5%) over virtual programming (22.2%).ConclusionsComprehensive pain screening is feasible within pediatric SCD care. Classifying patients by PPST risk may provide a means of triaging patients to appropriate services to address pain‐related psychosocial factors.

show abstract

Acupuncture as an Adjunctive Treatment for Pain in Hospitalized Children With Sickle Cell Disease

Cited by 11 publications

References 13 publications

Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease

Acupuncture for Pain Management in Pediatric Patients with Sickle Cell Disease

Massage therapy for children, adolescents, and young adults: Clinical delivery and effectiveness in hematology and oncology

Pain screening in youth with sickle cell disease: A quality improvement study

Contact Info

Product

Resources

About